Clinical Microbiology and Infection

Papers
(The H4-Index of Clinical Microbiology and Infection is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Cefiderocol for resistant Gram negatives: linking in vitro activity with clinical effectiveness767
Which trial do we need? Doxycycline in combination with ceftriaxone for the treatment of community-acquired pneumonia746
Outside Front Cover464
COVID-19 in special populations441
Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition214
‘Scope and aims of ESCMID guidelines’ by Scudeller et al.182
Re: Diagnostic limitations and challenges in current clinical guidelines and potential application of metagenomic sequencing to manage pulmonary invasive fungal infections in patients with haematologi177
‘Introducing new antibiotics for multidrug-resistant bacteria: obstacles and the way forward’ – author's response166
Re: ‘The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 20161
Re: Compromised access to antibiotics: addressing paediatric challenges in availability and responsible use145
Re: ‘Association between pertactin-producing Bordetella pertussis and fulminant pertussis in infants: a multicentre study in France, 2008–2019’ by Leroux et al.130
Exploring the limits of interferon-γ releasing assay screening in large-scale populations124
Limitations of genomic surveillance: a Clostridioides difficile case study in the Netherlands115
Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good?114
The diagnostic value of serum Borrelia burgdorferi antibodies and seroconversion after Lyme neuroborreliosis, a nationwide observational study112
Re: what is the role of epidemiological investigations in human Campylobacter outbreaks in the One Health and whole-genome sequencing era in Denmark?107
Fecal pharmacokinetics/pharmacodynamics characteristics of fidaxomicin and vancomycin against Clostridioides difficile infection elucidated by in vivo feces-based infectious evaluation models105
Optimizing antifungal therapies for Candida infections: evidence, resistance, and emerging approaches104
How to: Diagnose inborn errors of intrinsic and innate immunity to viral, bacterial, mycobacterial, and fungal infections103
Optimising the management of invasive candidiasis101
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab97
Non-biomedical factors affecting antibiotic use in the community: a mixed-methods systematic review and meta-analysis93
Pathogen and host determinants of extrapulmonary tuberculosis among 1035 patients in Frankfurt am Main, Germany, 2008–202391
Acquired fluconazole resistance and genetic clustering in Diutina (Candida) catenulata from clinical samples89
The importance of patient information and informed consent for unlicensed phage therapy88
Measuring the impact of hospitalization for infectious diseases on the quality of life of older patients in four European countries: the AEQUI longitudinal matched cohort study (2020–2023)82
A randomized trial of simultaneous versus sequential pneumococcal vaccination in elderly82
Re: ‘Dosing and route of administration of clindamycin given in combination with rifampicin’ by Magreault et al.82
Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern81
Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments80
Expected phenotypes and expert rules are important complements to antimicrobial susceptibility testing77
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis75
Large language models for antibiotic prescribing—moving the needle from ‘parlour trick’ to practical tool75
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate75
Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation71
The interplay between Epstein-Barr virus and cytomegalovirus reactivation following allogeneic haematopoietic cell transplantation in the era of primary cytomegalovirus prophylaxis71
Antimicrobial susceptibility of Mycobacterium abscessus and treatment of pulmonary and extra-pulmonary infections69
Myxovirus resistance protein A for discriminating between viral and bacterial lower respiratory tract infections in children – The TREND study67
European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists)66
Has the COVID-19 pandemic wiped out the seasonality of outpatient antibiotic use and influenza activity? A time-series analysis from 2014 to 202164
Should multiplex PCR testing be integrated into antimicrobial stewardship programs for paediatric community-acquired pneumonia in the emergency department?63
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review63
Acute cough in outpatients: what causes it, how long does it last, and how severe is it for different viruses and bacteria?62
What is the evidence base of used aggregated antibiotic resistance percentages to change empirical antibiotic treatment? A scoping review62
Safety of pertussis vaccination in pregnancy and effectiveness in infants: a Danish national cohort study 2019–202361
Evaluating stratified T-SPOT.TB results for diagnostic accuracy in tuberculosis disease: a retrospective cohort study with sensitivities, specificities, and predictive values60
Diagnostic accuracy of self-collected tongue swabs for Mycobacterium tuberculosis complex detection in individuals being assessed for tuberculosis in South Africa using the Xpert MTB/RIF Ultra assay60
Methenamine hippurate as prophylaxis for recurrent urinary tract infections in older women—a triple-blind, randomised, placebo-controlled, phase IV trial (ImpresU)60
The hidden link between cefiderocol resistance and increased virulence in Klebsiella pneumoniae: Insights from a TraDIS-based investigation60
Effects of azithromycin and doxycycline on the vaginal microbiota of women with urogenital Chlamydia trachomatis infection: a substudy of the Chlazidoxy randomized controlled trial58
Detection of fungal pathogens by a histomolecular approach using targeted-massive parallel sequencing on formalin-fixed tissues: a retrospective study58
Detection of viable SARS-CoV-2 in retrospective analysis of aerosol samples collected from hospital rooms of patients with COVID-1958
Laboratory innovations to diagnose invasive mould infections—what is relevant, what is not?58
Inferring antibiotic susceptibility from metagenomic data: dream or reality?58
Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China57
Aspergillus and host-pathogen interaction: focus on treatment-relevant aspects57
Comparing large language models for antibiotic prescribing in different clinical scenarios: which performs better?56
0.12345099449158